B. Zbar

2.9k total citations
47 papers, 2.0k citations indexed

About

B. Zbar is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, B. Zbar has authored 47 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in B. Zbar's work include Cancer, Hypoxia, and Metabolism (11 papers), Renal cell carcinoma treatment (6 papers) and Cancer Research and Treatments (6 papers). B. Zbar is often cited by papers focused on Cancer, Hypoxia, and Metabolism (11 papers), Renal cell carcinoma treatment (6 papers) and Cancer Research and Treatments (6 papers). B. Zbar collaborates with scholars based in United States, United Kingdom and Netherlands. B. Zbar's co-authors include Michael I. Lerman, W. Marston Linehan, H. J. Rapp, G.M. Glenn, M. Linehan, James R. Gnarra, Keith Foster, Paul A. Crossey, Malcolm A. Ferguson-Smith and Eamonn R. Maher and has published in prestigious journals such as Nucleic Acids Research, The Journal of Experimental Medicine and JNCI Journal of the National Cancer Institute.

In The Last Decade

B. Zbar

45 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Zbar United States 25 1.0k 869 734 450 311 47 2.0k
R. Becher Germany 26 1.4k 1.4× 357 0.4× 299 0.4× 658 1.5× 144 0.5× 103 3.1k
Mark L. Levitt United States 16 799 0.8× 349 0.4× 464 0.6× 1.1k 2.5× 216 0.7× 43 1.9k
Bjarni A. Agnarsson Iceland 27 925 0.9× 556 0.6× 347 0.5× 714 1.6× 234 0.8× 80 2.7k
Robert J.C. Slebos Netherlands 18 1.4k 1.3× 561 0.6× 903 1.2× 1.5k 3.4× 203 0.7× 24 2.7k
J. Whang‐Peng United States 22 1.1k 1.0× 327 0.4× 295 0.4× 867 1.9× 103 0.3× 46 2.2k
Ja‐Mun Chong Japan 22 880 0.9× 315 0.4× 368 0.5× 800 1.8× 533 1.7× 41 1.9k
Nadem Soufir France 22 877 0.8× 323 0.4× 231 0.3× 649 1.4× 124 0.4× 47 1.7k
Yasushi Kasai Japan 27 1.1k 1.1× 368 0.4× 427 0.6× 721 1.6× 449 1.4× 64 2.1k
Miller Cw United States 28 1.3k 1.3× 359 0.4× 232 0.3× 1.2k 2.6× 117 0.4× 59 2.5k
Cristiana Bellan Italy 29 965 0.9× 459 0.5× 209 0.3× 1.1k 2.4× 129 0.4× 94 2.2k

Countries citing papers authored by B. Zbar

Since Specialization
Citations

This map shows the geographic impact of B. Zbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Zbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Zbar more than expected).

Fields of papers citing papers by B. Zbar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Zbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Zbar. The network helps show where B. Zbar may publish in the future.

Co-authorship network of co-authors of B. Zbar

This figure shows the co-authorship network connecting the top 25 collaborators of B. Zbar. A scholar is included among the top collaborators of B. Zbar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Zbar. B. Zbar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toro, Jorge R., G.M. Glenn, Paul H. Duray, et al.. (1999). Birt-Hogg-Dubé Syndrome. Archives of Dermatology. 135(10). 1195–202. 257 indexed citations
2.
Miller, Mark Steven, B. Zbar, Krzysztof Ginalski, & Bogdan Lesyng. (1998). Structural basis of oncogenesis caused by point mutations in the kinase domain of the MET proto-oncogene. Cellular & Molecular Biology Letters. 3(3).
3.
Zbar, B. & Michael I. Lerman. (1998). Inherited Carcinomas of the Kidney. Advances in cancer research. 75. 163–203. 41 indexed citations
4.
Latif, Farida, Fuh-Mei Duh, Scott Bader, et al.. (1997). The human homolog of the rodent immediate early response genes, PC4 and TIS7, resides in the lung cancer tumor suppressor gene region on chromosome 3p21. Human Genetics. 99(3). 334–341. 24 indexed citations
5.
Choyke, Peter L., McClellan M. Walther, G.M. Glenn, et al.. (1997). Imaging Features of Hereditary Papillary Renal Cancers. Journal of Computer Assisted Tomography. 21(5). 737–741. 46 indexed citations
6.
Hanash, Kamal A., Joseph W. Aquilina, David M. Barrett, et al.. (1997). Clinical research priorities in Renal cell carcinoma. Cancer. 80(5). 999–1001. 2 indexed citations
7.
Zeiger, Martha A., B. Zbar, Harry R. Keiser, W. Marston Linehan, & James R. Gnarra. (1995). Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von hippel‐lindau disease‐associated, and familial pheochromocytoma. Genes Chromosomes and Cancer. 13(3). 151–156. 42 indexed citations
8.
Richards, Frances M., Stewart J. Payne, B. Zbar, et al.. (1995). Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Human Molecular Genetics. 4(11). 2139–2143. 105 indexed citations
9.
Richards, Frances M., Farida Latif, Michael I. Lerman, B. Zbar, & Eamonn R. Maher. (1993). Taql and Pstl RFLPs in the von Hippel–Lindau disease gene (VHL). Human Molecular Genetics. 2(10). 1750–1750. 9 indexed citations
10.
Crossey, Paul A., Eamonn R. Maher, Michael H. Jones, et al.. (1993). Genetic linkage between Von Hippel—Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus. Human Molecular Genetics. 2(3). 279–282. 43 indexed citations
12.
Choyke, Peter L., G.M. Glenn, McClellan M. Walther, et al.. (1992). The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients.. American Journal of Roentgenology. 159(6). 1229–1234. 140 indexed citations
13.
Anglard, Patrick, Kálmán Tory, Hiltrud Brauch, et al.. (1991). Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.. PubMed. 51(4). 1071–7. 140 indexed citations
14.
Brauch, Hiltrud, Kálmán Tory, Adi F. Gazdar, et al.. (1990). Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer. Genes Chromosomes and Cancer. 1(3). 240–246. 83 indexed citations
15.
Yano, Tomohiro, M. Linehan, Michael I. Lerman, et al.. (1989). Genetic Changes in Human Adrenocortical Carcinomas. JNCI Journal of the National Cancer Institute. 81(7). 518–519. 96 indexed citations
16.
Sukumar, Saraswati, et al.. (1981). Treatment by limited surgery and specific immunization of guinea pigs with stage II experimental cancer.. The Journal of Experimental Medicine. 154(2). 253–261. 3 indexed citations
17.
Zbar, B., G Canti, H. J. Rapp, J. Bier, & Tibor Borsos. (1979). Regression of established oral tumors after intralesional injection of living BCG OR BCG cell walls. Cancer. 43(4). 1304–1307. 3 indexed citations
18.
Harmel, Richard P. & B. Zbar. (1975). Tumor Suppression by pyran Copolymer: Correlation With Production of Cytotoxic Macrophages. JNCI Journal of the National Cancer Institute. 54(4). 989–92. 28 indexed citations
19.
Bast, Robert C., et al.. (1975). Immunotherapy of experimental cancer with BCG and surgery. 1. 333–336. 1 indexed citations
20.
Bast, Robert C., et al.. (1974). Brief Communication: Intracolonlc Injection of BeG in the Rhesus Monkey. JNCI Journal of the National Cancer Institute. 53(5). 1423–1426. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026